Zoltán Nagy

DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma

Ian W. Flinn, Carole B. Miller, Kirit M. Ardeshna et al. · Journal of Clinical Oncology · 2019 · 264 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

Michele Spina, Zoltán Nagy, Josep‐María Ribera et al. · Annals of Oncology · 2015 · 89 citations · Full text

Medicine, Hematology, Pharmacotherapy +10

Potency and Specificity of the Pharmacological Action of a New, Antiasthmatic, Topically Administered Soft Steroid, Etiprednol Dicloacetate (BNP-166)

István Kurucz, Szilveszter Tóth, Klára Németh et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 21 citations

Life Sciences, Immunology, Pharmacology +17

Biportal endoscopic technique in the treatment of spinal stenosis: early clinical experiences and results

Gábor Czigléczki, Zoltán Nagy, Csaba Padányi et al. · Neurological Research · 2020 · 12 citations

Medicine, Neurosurgery, Surgery +14

Cerebellar <i>Cladophialophora bantiana</i> infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab

Claire Hemmaway, Etienne Laverse, Meredydd Nicholas et al. · British Journal of Haematology · 2011 · 10 citations · Full text

Medicine, Neurology, Oncology +17